These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 17144651

  • 1. Molecular recognition by Escherichia coli UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase is modulated by bound metal ions.
    Hernick M, Fierke CA.
    Biochemistry; 2006 Dec 12; 45(49):14573-81. PubMed ID: 17144651
    [Abstract] [Full Text] [Related]

  • 2. UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase of Escherichia coli is a zinc metalloenzyme.
    Jackman JE, Raetz CR, Fierke CA.
    Biochemistry; 1999 Feb 09; 38(6):1902-11. PubMed ID: 10026271
    [Abstract] [Full Text] [Related]

  • 3. Catalytic mechanism and molecular recognition of E. coli UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase probed by mutagenesis.
    Hernick M, Fierke CA.
    Biochemistry; 2006 Dec 26; 45(51):15240-8. PubMed ID: 17176046
    [Abstract] [Full Text] [Related]

  • 4. Activation of Escherichia coli UDP-3-O-[(R)-3-hydroxymyristoyl]-N-acetylglucosamine deacetylase by Fe2+ yields a more efficient enzyme with altered ligand affinity.
    Hernick M, Gattis SG, Penner-Hahn JE, Fierke CA.
    Biochemistry; 2010 Mar 16; 49(10):2246-55. PubMed ID: 20136146
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. UDP-3-O-((R)-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase functions through a general acid-base catalyst pair mechanism.
    Hernick M, Gennadios HA, Whittington DA, Rusche KM, Christianson DW, Fierke CA.
    J Biol Chem; 2005 Apr 29; 280(17):16969-78. PubMed ID: 15705580
    [Abstract] [Full Text] [Related]

  • 7. A fluorescence-based homogeneous assay for measuring activity of UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase.
    Wang W, Maniar M, Jain R, Jacobs J, Trias J, Yuan Z.
    Anal Biochem; 2001 Mar 29; 290(2):338-46. PubMed ID: 11237337
    [Abstract] [Full Text] [Related]

  • 8. Antibacterial agents that target lipid A biosynthesis in gram-negative bacteria. Inhibition of diverse UDP-3-O-(r-3-hydroxymyristoyl)-n-acetylglucosamine deacetylases by substrate analogs containing zinc binding motifs.
    Jackman JE, Fierke CA, Tumey LN, Pirrung M, Uchiyama T, Tahir SH, Hindsgaul O, Raetz CR.
    J Biol Chem; 2000 Apr 14; 275(15):11002-9. PubMed ID: 10753902
    [Abstract] [Full Text] [Related]

  • 9. Crystal structure of LpxC, a zinc-dependent deacetylase essential for endotoxin biosynthesis.
    Whittington DA, Rusche KM, Shin H, Fierke CA, Christianson DW.
    Proc Natl Acad Sci U S A; 2003 Jul 08; 100(14):8146-50. PubMed ID: 12819349
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of lipid A biosynthesis as the primary mechanism of CHIR-090 antibiotic activity in Escherichia coli.
    Barb AW, McClerren AL, Snehelatha K, Reynolds CM, Zhou P, Raetz CR.
    Biochemistry; 2007 Mar 27; 46(12):3793-802. PubMed ID: 17335290
    [Abstract] [Full Text] [Related]

  • 11. Amphipathic benzoic acid derivatives: synthesis and binding in the hydrophobic tunnel of the zinc deacetylase LpxC.
    Shin H, Gennadios HA, Whittington DA, Christianson DW.
    Bioorg Med Chem; 2007 Apr 01; 15(7):2617-23. PubMed ID: 17296300
    [Abstract] [Full Text] [Related]

  • 12. UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase (LpxC) inhibitors: a new class of antibacterial agents.
    Zhang J, Zhang L, Li X, Xu W.
    Curr Med Chem; 2012 Apr 01; 19(13):2038-50. PubMed ID: 22414079
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Structure of the metal-dependent deacetylase LpxC from Yersinia enterocolitica complexed with the potent inhibitor CHIR-090 .
    Cole KE, Gattis SG, Angell HD, Fierke CA, Christianson DW.
    Biochemistry; 2011 Jan 18; 50(2):258-65. PubMed ID: 21171638
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A method to assay inhibitors of lipopolysaccharide synthesis.
    Hernick M, Fierke CA.
    Methods Mol Med; 2008 Jan 18; 142():143-54. PubMed ID: 18437312
    [Abstract] [Full Text] [Related]

  • 18. Kinetic analysis of the zinc-dependent deacetylase in the lipid A biosynthetic pathway.
    McClerren AL, Zhou P, Guan Z, Raetz CR, Rudolph J.
    Biochemistry; 2005 Feb 01; 44(4):1106-13. PubMed ID: 15667204
    [Abstract] [Full Text] [Related]

  • 19. Structure of the bacterial deacetylase LpxC bound to the nucleotide reaction product reveals mechanisms of oxyanion stabilization and proton transfer.
    Clayton GM, Klein DJ, Rickert KW, Patel SB, Kornienko M, Zugay-Murphy J, Reid JC, Tummala S, Sharma S, Singh SB, Miesel L, Lumb KJ, Soisson SM.
    J Biol Chem; 2013 Nov 22; 288(47):34073-34080. PubMed ID: 24108127
    [Abstract] [Full Text] [Related]

  • 20. Structure of the LpxC deacetylase with a bound substrate-analog inhibitor.
    Coggins BE, Li X, McClerren AL, Hindsgaul O, Raetz CR, Zhou P.
    Nat Struct Biol; 2003 Aug 22; 10(8):645-51. PubMed ID: 12833153
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.